Misoprostol-only abortion pill study
Part of Women’s health & pregnancy clinical trials.
This study tests if taking only misoprostol (instead of the usual two-pill regimen) is safe and effective for ending early pregnancy. It may offer a simpler option for people up to 11 weeks pregnant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are up to 11 weeks pregnant (77 days or less).
- You have a positive pregnancy test.
- You are 14 or older (or 18+ in states that require parental involvement).
- You can read and speak English or Spanish.
- You have a phone or device that can get texts, emails, or calls for surveys.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This study compares two medications—letrozole plus misoprostol versus misoprostol alone—to see which is more effective for ending a pregnancy in the second trimester (14–20 weeks) after the fetus has stopped developing. The goal is to find a safer, more comfortable method for women who need this procedure.
This trial tests whether taking letrozole before misoprostol shortens the time needed to complete a missed abortion, which is when the pregnancy stops developing but the body hasn't expelled the tissue. If effective, it could reduce the waiting time and make the process more efficient.
This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.
This study compares two ways of taking medicine (by mouth or vaginal insertion) to safely manage a miscarriage that was discovered on ultrasound between 8–16 weeks of pregnancy. The goal is to see which method works better and causes fewer side effects.
This trial tests a medication called misoprostol to help the body expel pregnancy tissue after a fetal death between 18 and 24 weeks. It may be an option for women who have not had a previous C-section or have had only one.
Hear when a new Abortion, Medical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.